Search results
Results From The WOW.Com Content Network
The longest time between discharge and relapse was over 3 years. Seven dogs experienced relapse more than once and one dog relapsed five times before being euthanised. [16] In dogs with a platelet count below < 30,000 cells/μL there is an increased risk of spontaneous haemorrhage; [26] however, haemorrhage cannot be predicted in dogs with IMT ...
ITP can be difficult to distinguish from gestational thrombocytopenia (which is by far the most common cause of thrombocytopenia in pregnancy). Unlike ITP, the platelet count in gestational thrombocytopenia rarely goes below 100,000, and a platelet count below 80,000 is even more rare (seen in less than 0.1% of cases of gestational ...
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...
Thrombotic thrombocytopenic purpura (TTP) initially presents with a range of symptoms that may include severe thrombocytopenia (platelet count usually < 30,000/mm³), microangiopathic hemolytic anemia (evidenced by schistocytes in the blood smear), and various clinical signs such as petechiae, purpura, neurologic symptoms, myocardial ischemia ...
The leaflets of the valve become thickened and nodular, leading to mitral valve regurgitation and volume overload of the left side of the heart. Cavalier King Charles Spaniels and Dachshunds have an inherited form of this disease. [49] Dilated cardiomyopathy (DCM) is a disease of heart muscle resulting in decreased myocardial contractility. The ...
Fostamatinib is a drug used to treat adults with low platelet count due to chronic immune thrombocytopenia (ITP) when a prior treatment for ITP has not worked well enough. Chronic immune thrombocytopenia is an autoimmune bleeding disorder where the blood doesn't clot as it should because of a low platelet count. [4] [6] [3]
Plasma exchange offers the quickest short-term answer to removing harmful autoantibodies; however, the production of autoantibodies by the immune system must also be suppressed, usually by the use of medications such as cyclophosphamide, cyclosporine, mycophenolate mofetil, prednisone, rituximab, or a mixture of these.
The most common side effects of IV HD-MTX are neutropenia, thrombocytopenia, sore mouth, and kidney and liver dysfunction. These effects gradually disappear upon termination of CNS prophylaxis. [4] In rare occasions, IV HD-MTX can lead to nephropathy when drug precipitation occurs in renal tubules, causing direct damage.